Proscia Releases New Version of Pathology Platform
The update integrates artificial intelligence into the system architecture to assist with case review, biomarker discovery, and laboratory operations.
The update integrates artificial intelligence into the system architecture to assist with case review, biomarker discovery, and laboratory operations.
The funding, allocated to the Centers for Disease Control and Prevention, aims to establish more accurate normal ranges for children’s medical results.
Research suggests that only 12% of men receiving testosterone prescriptions underwent appropriate testing.
The company introduced systems for single-cell proteomics, clinical sample processing, and spatial proteomics.
The test combines genomic risk assessment and digital pathology analysis to help clinicians tailor monitoring strategies.